Find Your Daily Voice
Torrington
Your Local News for Torrington, Connecticut
Monday, nov 25
38°
Follow
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Torrington
Follow
Find Your Daily Voice
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Real Estate
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2024 Cantata Media
38°
Monday, nov 25
Tag:
Adolescents
News
Covid-
19: Reports Of Heart Inflammation In Some Adolescents Getting Vaccines Prompt CDC Probe
Red flags are flying for federal health officials following reports of heart inflammation in some adolescents who have been getting the COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) is getting involved as concerns grow. In response to the recent reports, the CDC called for an emergency meeting later this week. According to reports, the CDC is investigating more than 225 cases of heart inflammation among adolescents who received the vaccine. Most of the victims reporting cases were teens or men in their early 20s. The CDC said that among those recovering from COV…
News
Covid-
19: Moderna Asks FDA To Approve Vaccines For Those Ages 12 To 17
Moderna has requested an emergency use authorization from the Food and Drug Administration (FDA) for its COVID-19 vaccine in adolescents between the ages of 12 and 17. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-BioNTech vaccine, which was given the green light for use earlier this month. In their study, Moderna found no cases of COVID-19 in participants who received two doses of th…
News
Covid-
19: CDC Issues Brand-New Guidance For Summer Camps
The Centers for Disease Control & Prevention (CDC) has just issued brand-new guidance for summer camps amid the COVID-19 pandemic. Vaccinated adolescents do not need to wear masks at camp, and younger campers who have not been vaccinated can usually shed face coverings when outdoors, the CDC said on Friday, May 28. For camps where everyone is fully vaccinated prior to the start of camp, it is safe to return to full capacity, without masking, and without physical distancing in accordance with the CDC’s Interim Public Health Recommendations for Fully Vaccinated People, except where requir…
News
Covid-
19: Vaccine 'Safe, Highly Effective' In Kids 12-17, Moderna Says, Will Seek FDA Approval
Moderna’s COVID-19 vaccine has proven effective and safe for adolescents and teens between the ages of 12 and 17, the company announced, as it prepares to seek federal authorization. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. Moderna officials said that they plan to apply for federal approval from the Food and Drug Administration (FDA) to use the vaccine in that age group in June. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-Bi…
News
Covid-
19: CDC Issues Brand-New Guidance On Mask-Wearing Indoors
The Centers for Disease Control and Prevention (CDC) is easing indoor mask-wearing guidance for Americans who are fully vaccinated for COVID-19. On Thursday afternoon, May 13, CDC Director Dr. Rochelle Walensky announced the new guidance at a White House briefing, saying that anyone who has received both shots of the Pfizer or Moderna vaccine, or the one-dose Johnson & Johnson shot can safely stop wearing masks indoors, except under some circumstances. The new guidance calls for continued mask-wearing in more crowded indoor spaces such as on mass transportation, hospitals, prisons, or …
News
Covid-
19: Pfizer Will Seek Vaccine Rollout For Younger Teens After Encouraging Trial Results
Clinical trials of the Pfizer/BioNTech’s COVID-19 vaccine showed that it has a 100 percent efficacy in adolescents and is well-tolerated in minors between the ages of 12 and 15, paving the way for distribution, the companies announced. Officials said that initial trials were fruitful, and they plan to submit the data to the U.S. Food and Drug Administration for expanded emergency use authorization of the two-dose vaccine in adolescents. According to Pfizer, the third phase of the clinical trial included 2,260 participants between the ages of 12 and 15, which found that strong antibody respo…